Pharmacological effects of harmine and its derivatives: a review

L Zhang, D Li, S Yu - Archives of pharmacal research, 2020 - Springer
Harmine is isolated from the seeds of the medicinal plant, Peganum harmala L., and has
been used for thousands of years in the Middle East and China. Harmine has many …

The DYRK family of kinases in cancer: molecular functions and therapeutic opportunities

J Boni, C Rubio-Perez, N López-Bigas, C Fillat… - Cancers, 2020 - mdpi.com
DYRK (dual-specificity tyrosine-regulated kinases) are an evolutionary conserved family of
protein kinases with members from yeast to humans. In humans, DYRKs are pleiotropic …

A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum

S Li, X Cheng, C Wang - Journal of Ethnopharmacology, 2017 - Elsevier
Ethnopharmacological relevance The plants of the genus Peganum have a long history as a
Chinese traditional medicine for the treatment of cough, hypertension, diabetes, asthma …

Multiple molecular mechanisms to overcome multidrug resistance in cancer by natural secondary metabolites

MZ El-Readi, AM Al-Abd, MA Althubiti… - Frontiers in …, 2021 - frontiersin.org
Plant secondary metabolites (SMs) common natural occurrences and the significantly lower
toxicities of many SM have led to the approaching development and use of these …

Peganum harmala Alkaloids Self-Assembled Supramolecular Nanocapsules with Enhanced Antioxidant and Cytotoxic Activities

SA Fahmy, MY Issa, BM Saleh, MR Meselhy… - ACS …, 2021 - ACS Publications
Amphiphilic macrocycles, such as p-sulfonatocalix [6] arenes (p-SC6), have demonstrated
great potential in designing synthetic nanovesicles based on self-assembly approaches …

Development of kinase-selective, harmine-based DYRK1A inhibitors that induce pancreatic human β-cell proliferation

K Kumar, P Wang, R Sanchez, EA Swartz… - Journal of medicinal …, 2018 - ACS Publications
DYRK1A has been implicated as an important drug target in various therapeutic areas,
including neurological disorders and oncology. DYRK1A has more recently been shown to …

Harmine induces anticancer activity in breast cancer cells via targeting TAZ

Y Ding, J He, J Huang, T Yu, X Shi… - International …, 2019 - spandidos-publications.com
Harmine (HM) is a β‑carboline alkaloid found in multiple medicinal plants. It has been used
in folk medicine for anticancer therapy; however, the molecular mechanism of HM on human …

Synthesis and biological validation of a harmine-based, central nervous system (CNS)-avoidant, selective, human β-cell regenerative dual-specificity tyrosine …

K Kumar, P Wang, J Wilson, V Zlatanic… - Journal of medicinal …, 2020 - ACS Publications
Recently, our group identified that harmine is able to induce β-cell proliferation both in vitro
and in vivo, mediated via the DYRK1A-NFAT pathway. Since, harmine suffers from a lack of …

Synthesis and mechanisms of action of novel harmine derivatives as potential antitumor agents

XF Zhang, R Sun, Y Jia, Q Chen, RF Tu, K Li… - Scientific reports, 2016 - nature.com
A series of novel harmine derivatives bearing a benzylindine substituent in position-1 of β-
carboline ring were synthesized and evaluated as antitumor agents. The N2-benzylated β …

Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and …

M Tarpley, HO Oladapo, D Strepay, TB Caligan… - European Journal of …, 2021 - Elsevier
ABSTRACT DYRK1A (dual-specificity tyrosine phosphorylation-regulated kinase 1a) is
highly expressed in glioma, an aggressive brain tumor, and has been proposed as a …